The Westy Bar & Grill, 279 W. State St., PA, United States
Latest report:
Covid-19 Violations
3 years ago
It was ordered to closed for continuing to defy the closing orders due to COVID-19 and operating in any manner.
Source: www.pennlive.com
Source: www.pennlive.com
19
Ownership's family tested positive for Covid-19
3 years ago
A Berks County restaurant that had defied a state COVID-19 mandate forbidding indoor dining has temporarily closed after a member of its ownership's family tested positive for the coronavirus.
Source: www.readingeagle.com
Source: www.readingeagle.com
19
Covid-19 Violations
3 years ago
Closure Date: 12-17-2020
It was closed for defying temporary COVID-19 mitigation order prohibiting dine-in service.
Source: www.readingeagle.com
It was closed for defying temporary COVID-19 mitigation order prohibiting dine-in service.
Source: www.readingeagle.com
19
Related Reports
Covid 19 infection control protocols denied, Fort Collins, CO, USA
1 year ago •reported by user-gwkj6867
Employee tested positive for Covid. Admin threatened the job to report for job abandonment if left work.
157
HCA Virginia Sports Medicine Physical Therapy, HCA Virginia Sports Medicine 1115 Boulders Pkwy, Richmond, VA 23225, United States
2 years ago •reported by user-qxhjg954
Two of the Physical Therapy men chronically are not wearing masks properly (ie below their noses) and working closely with patients.
438
Closure Date: 01-26-2022
The Big Board repeatedly refused to enforce the city’s new vaccine card entry requirement.
Source: www.wusa9.com
The Big Board repeatedly refused to enforce the city’s new vaccine card entry requirement.
Source: www.wusa9.com
896
Closure Date: 01/14/2022
A temporary order to close indoor dining was issued after patrons and attendees of the establishment were not being screened properly for proof of COVID-19 vaccination or a COVID-19 test result.
Source: www.houston-today.com
A temporary order to close indoor dining was issued after patrons and attendees of the establishment were not being screened properly for proof of COVID-19 vaccination or a COVID-19 test result.
Source: www.houston-today.com
38
LA Fitness Complaint, LA Fitness, Rockaway Turnpike, Lawrence, NY, USA
2 years ago •reported by user-hvpy8923
Started going to the gym a couple of months ago, not once was I asked to show proof of vaccination. Masks are not enforced, cleaning is inconsistent.
1.4K
Beaqequeen Co. Ltd, Hamburg, Hamburg, Germany
4 weeks ago •reported by user-tvtcq856
No goods received Order was placed on February 2, 2024 and today 18.03. 2024 I still haven't received anything. These are 2 crossback bags worth €51.98. Is from Beaqequeen and the order name was high-point. de. The goods are supposed to be in Bremen, but that's been
…
going on since 01.03. 2024 SO STAY AWAY
or even high point. de
or even high point. de
72
Power Outage, Hamburg, New York 14075, USA
3 months ago
On January 10, In Western New York after winds gusting to 70 mph or more swept across the region, knocking down trees and power lines and damaging buildings. National Grid's website reported about 19,375 without power, while NYSEG had about 14,240. In Erie County, Hamburg and other
…
communities along the Lake Erie shore south of Buffalo were most severely affected. Thousands also were without power in the Dunkirk and Jamestown areas.
National Grid: outagemap.ny.nationalgridus.com/
NYSEG: outagemap.nyseg.com/
Source: buffalonews.com/news/local/weather/more-than-25-000-power-customers-in-erie-chautauqua-counties-without-electricity/article_d49cc254-af00-11ee-9d08-77403d5544aa.html
Published: 2024-01-09
National Grid: outagemap.ny.nationalgridus.com/
NYSEG: outagemap.nyseg.com/
Source: buffalonews.com/news/local/weather/more-than-25-000-power-customers-in-erie-chautauqua-counties-without-electricity/article_d49cc254-af00-11ee-9d08-77403d5544aa.html
Published: 2024-01-09
200
Power Outage, Hamburg, Sussex County, NJ, USA
3 months ago
According to First Energy’s outage map, there are 3,358 customers affected by power outages in Sussex County in New Jersey as of Friday morning Dec, 29. An outage is affecting 1,379 customers in Hamburg Borough. The cause of the outage is currently unknown, however, additional Crews were
…
Requested. The estimated time for restoration is 10:30 a.m. Crews are investigating the cause of the outage.
Outage link: outages.firstenergycorp.com/nj.html?address=07461
Source: www.firstenergycorp.com/fehome.html
Published: 2023-12-29
Outage link: outages.firstenergycorp.com/nj.html?address=07461
Source: www.firstenergycorp.com/fehome.html
Published: 2023-12-29
10
Power Outage, Hamburg, NY, USA
8 months ago
Massive Power Outages accross New York State. When the storms started to blow in, portions of Hamburg and Lake Shore lost power almost immediately. According to National Grid Outage map, as of 4:30 on Friday morning, there are more than 3,000 customers without power and the estimated
…
restoration is around 12 noon.
Outage link: outagemap.ny.nationalgridus.com/
Source: wyrk.com/power-outages-new-york-state/
Published: 2023-07-21
Outage link: outagemap.ny.nationalgridus.com/
Source: wyrk.com/power-outages-new-york-state/
Published: 2023-07-21
200
Over 1,700 people were without power in Hamburg late Friday, A crash resulted in a downed utility pole, which led to over 1,700 people losing power. As of Saturday morning, the number has dwindled to 230 outages."
num
Outage link: outagemap.nyseg.com/
Source: www.wivb.com/news/local-news/erie-county/hamburg/over-2500-without-power-in-hamburg/
Published: 2023-04-22
num
Outage link: outagemap.nyseg.com/
Source: www.wivb.com/news/local-news/erie-county/hamburg/over-2500-without-power-in-hamburg/
Published: 2023-04-22
200
Recent Interesting Reports
Scammed by Heather's Motty, 2207 Summit Avenue, Union City, NJ, USA
1 week ago •reported by user-jxhnt677
I ordered a starlink wi-fi. Received 2 gree dots.
2.8K
K
user-khbjp759
I received two pks from different address with dics also No phone # or e-mail
- 1 week ago
- Reply
Want a refund!, Deer Lodge, MT, USA
1 week ago •reported by user-hnvkg974
I received a package from Heathers Motty in Union City N.J. It was a PZGONE Streaming Device and the product is useless. I want a refund paid to my Paypal account.
1
Crap I didn’t order, Broadview Heights, Ohio, USA
1 week ago •reported by user-dtfbw861
Received some crap from Heathersb Mottysy that I did not order.
335
Scam, Lexington, KY 40503, USA
2 weeks ago •reported by user-prkj4722
I did not get my parcel . In my mail box I just found parcel bag but bag was empty . Please find my parcel. I didn't get my parcel. When I check my mail box I just found empty parcel bag having usps tracking number 9261292700545500070679****. But where is my parcel?
238
Same subgenix thing, Tampa, FL 33675, USA
2 weeks ago •reported by user-wybh3149
Came in the mail from the Tampa fulfillment center , is a face and hand lotion did not order ANYTHING
522
Verti products, Tampa FL. 33626
1 week ago •reported by user-dtwk5977
Yes. 1 ounce of some dietary supplement
InfuTronix Nimbus Ambulatory Infusion Pump System recalled due to customer complaints, USA
3 weeks ago •source www.fda.gov
Recall notice
InfuTronix, LLC has announced a voluntary recall of the Nimbus Ambulatory Infusion Pump System, including Nimbus II PainPro, Nimbus II Flex, Nimbus II Plus, Nimbus II EpiD and Nimbus II EMS from the US Market due to a high number (3698) of customer complaints related to the
…
Nimbus Infusion Pump systems dated May 2019 to August 2023.
Evaluation of complaint data has identified several potential product issues:
- Battery Power may potentially affect the performance of the pump by causing an immediate power off event.
- Upstream Occlusion, as noted by the upstream occlusion alarm, occurs when there is a block in flow of the proximal end of the administration set.
- System Errors, as noted by the System Error alarm which causes the pump to suspend the infusion.
- Drug product egress from certain administration set bonding points, which may potentially result in drug product leaking from the device.
- Flow Rate (high or low) which may potentially lead to the pump infusing an inaccurate delivery of the drug.
- Pump Housing design which may potentially result in damage over time to certain areas of the housing responsible for administration set engagement, leading to false occlusions and flow rate inaccuracies.
These product issues were identified through the InfuTronix post-market surveillance system and evaluated through the InfuTronix Corrective Action/Preventive Action (CAPA) system. InfuTronix has determined that the best corrective and preventive action to address the identified product issues and potential outcomes is a redesign of the Nimbus Infusion Pump system. The redesign of the system will allow InfuTronix to improve several aspects of the product including mechanics, electronics, software, and housing design as well as aspects of the administration set. Given the number of anticipated design improvements and the extensive requirement for design, verification, and validation, InfuTronix believes a new premarket notification(s) and clearance from FDA may be required. As such, InfuTronix is seeking to remove the system from the market while these improvements and design changes are being made and a new clearance(s) is obtained.
A health hazard evaluation (HHE) was performed by an independent physician to evaluate routine post-market complaint failure modes associated with the Nimbus family of infusion pumps. The HHE determined that the common device failure modes pose a low risk to users.
The Nimbus Infusion Pump system has been distributed throughout the United States since October 17, 2014 until February 21, 2024. It has never been distributed internationally. Affected devices have the following Unique Device Identification numbers associated with them:
- Nimbus Ambulatory Infusion Pump 00817170020000
- Nimbus II PainPRO 00817170020086
- Nimbus II Flex 00817170020093
- Nimbus II Plus 00817170020161
- Nimbus II EpiD 00817170020376
- Nimbus II EMS 00817170020109
Users may continue to use the Nimbus Infusion Pump system and associated infusion sets during this removal process. Users should be aware of the signs indicating a potential issue with the pump (How to recognize that a device may fail):
- Battery – The infusion pump will brown out (fail-safe). The user will see that the pump has shut off. Additionally, the LED screen may flicker prior to failure, indicating a potential battery issue.
- Upstream Occlusion - Auditory and visual occlusion alarm alerts the user of the occlusion.
- System Error - Auditory and visual system error alarm will alert the user.
- Drug Product Egress – The user may notice leaking drug from the pump pouch or infusion set or feel wetness from the drug product.
- Flow Rate (high/low) - Auditory and visual occlusion alarm for low flow will alert the user of occlusion. The user will notice residual volume remaining at the end of therapy. High flow rate may be associated with shortened infusion times.
- Pump Housing Damage - The user may notice broken latches, hinges, or cracks in the housing and/or user may notice that the device is difficult to assemble prior to use.
Infutronix has already notified customers with a letter that details the products impacted, reason for the voluntary removal, risk to health assessment, how to recognize the device may fail and actions to be taken by the customer/user.
The continued use of the Nimbus Infusion Pump system and associated infusion sets is safe during this removal process. Users should be aware of the signs indicating a potential issue with the pump as described above, “How to recognize that a device may fail”. As with any use, health care providers (HCPs) should read the Instructions for Use (IFU) and follow those closely to ensure proper performance of the pump with its associated accessory set. Further, HCPs should educate patients on proper use of the pump and accessories, and potential operational concerns. As a reminder to HCPs,
- When replacing batteries, only new batteries should be used. Care should be taken to ensure that old and new batteries are not confused when completing the replacement. When resetting the battery state, HCPs are encouraged to pay close attention to the device indicator lights and LED screen indicating battery life.
- HCPs should take care to clear an occlusion alarm properly. The battery should not be cycled (turned on/off) to clear the occlusion alarm. If the occlusion alarm cannot be cleared, a new pump should be used. Patients should be educated that silencing the alarm does not clear the occlusion.
- Due to the potential ambulatory use of the pump, patients may carry the drug product dispensing pouch in a carrying pack. Patients should be educated that impeding the tubing set or placing pressure on the device (leaning against it, sitting on it) may cause the device to malfunction.
- HCPs are encouraged to educate patients on potential drug leakage and establish appropriate containment protocols for users to follow.
HCPs should ensure users are educated to recognize audio and visual alarms and inspect their device for damage. Any difficulties or abnormalities noted with the pump or accessories should result in immediate discontinued use of the pump and notification to the HCP. Customers of InfuTronix who have Nimbus Infusion Pumps and associated infusion sets in their possession should contact InfuTronix customer service, where they will be instructed on the Return Material Authorization (RMA) process to be followed for returning both the Nimbus Infusion Pumps and associated infusion sets.
Customers who purchase the Nimbus Infusion Pump and/or associated infusion sets from a distributor should contact their distributor directly and receive instructions on the RMA process to be followed. As the device will not be available or supported after June 20, 2024, InfuTronix encourages the healthcare provider to seek alternative methods of drug product infusion appropriate for their patient’s needs, based on their medical expertise, at the earliest possible opportunity. InfuTronix is removing the Nimbus Infusion Pump Systems from the market.
The products will no longer be supported by InfuTronix for either Nimbus Infusion Pumps or related infusion sets beyond June 20, 2024. To return Nimbus products customers should follow the instructions provided in the Medical Device Removal letter that was sent by InfuTronix, contact InfuTronix customer service or their local distributor.
Company name: InfuTronix, LLC
Brand name: Nimbus
Product recalled: Nimbus Pump System
Reason of the recall: Recall due to a high number (3698) of customer complaints related to the Nimbus Infusion Pump systems
FDA Recall date: March 20, 2024
Source: www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/voluntary-removal-announcement-infutronix-nimbus-ambulatory-infusion-pump-system
Evaluation of complaint data has identified several potential product issues:
- Battery Power may potentially affect the performance of the pump by causing an immediate power off event.
- Upstream Occlusion, as noted by the upstream occlusion alarm, occurs when there is a block in flow of the proximal end of the administration set.
- System Errors, as noted by the System Error alarm which causes the pump to suspend the infusion.
- Drug product egress from certain administration set bonding points, which may potentially result in drug product leaking from the device.
- Flow Rate (high or low) which may potentially lead to the pump infusing an inaccurate delivery of the drug.
- Pump Housing design which may potentially result in damage over time to certain areas of the housing responsible for administration set engagement, leading to false occlusions and flow rate inaccuracies.
These product issues were identified through the InfuTronix post-market surveillance system and evaluated through the InfuTronix Corrective Action/Preventive Action (CAPA) system. InfuTronix has determined that the best corrective and preventive action to address the identified product issues and potential outcomes is a redesign of the Nimbus Infusion Pump system. The redesign of the system will allow InfuTronix to improve several aspects of the product including mechanics, electronics, software, and housing design as well as aspects of the administration set. Given the number of anticipated design improvements and the extensive requirement for design, verification, and validation, InfuTronix believes a new premarket notification(s) and clearance from FDA may be required. As such, InfuTronix is seeking to remove the system from the market while these improvements and design changes are being made and a new clearance(s) is obtained.
A health hazard evaluation (HHE) was performed by an independent physician to evaluate routine post-market complaint failure modes associated with the Nimbus family of infusion pumps. The HHE determined that the common device failure modes pose a low risk to users.
The Nimbus Infusion Pump system has been distributed throughout the United States since October 17, 2014 until February 21, 2024. It has never been distributed internationally. Affected devices have the following Unique Device Identification numbers associated with them:
- Nimbus Ambulatory Infusion Pump 00817170020000
- Nimbus II PainPRO 00817170020086
- Nimbus II Flex 00817170020093
- Nimbus II Plus 00817170020161
- Nimbus II EpiD 00817170020376
- Nimbus II EMS 00817170020109
Users may continue to use the Nimbus Infusion Pump system and associated infusion sets during this removal process. Users should be aware of the signs indicating a potential issue with the pump (How to recognize that a device may fail):
- Battery – The infusion pump will brown out (fail-safe). The user will see that the pump has shut off. Additionally, the LED screen may flicker prior to failure, indicating a potential battery issue.
- Upstream Occlusion - Auditory and visual occlusion alarm alerts the user of the occlusion.
- System Error - Auditory and visual system error alarm will alert the user.
- Drug Product Egress – The user may notice leaking drug from the pump pouch or infusion set or feel wetness from the drug product.
- Flow Rate (high/low) - Auditory and visual occlusion alarm for low flow will alert the user of occlusion. The user will notice residual volume remaining at the end of therapy. High flow rate may be associated with shortened infusion times.
- Pump Housing Damage - The user may notice broken latches, hinges, or cracks in the housing and/or user may notice that the device is difficult to assemble prior to use.
Infutronix has already notified customers with a letter that details the products impacted, reason for the voluntary removal, risk to health assessment, how to recognize the device may fail and actions to be taken by the customer/user.
The continued use of the Nimbus Infusion Pump system and associated infusion sets is safe during this removal process. Users should be aware of the signs indicating a potential issue with the pump as described above, “How to recognize that a device may fail”. As with any use, health care providers (HCPs) should read the Instructions for Use (IFU) and follow those closely to ensure proper performance of the pump with its associated accessory set. Further, HCPs should educate patients on proper use of the pump and accessories, and potential operational concerns. As a reminder to HCPs,
- When replacing batteries, only new batteries should be used. Care should be taken to ensure that old and new batteries are not confused when completing the replacement. When resetting the battery state, HCPs are encouraged to pay close attention to the device indicator lights and LED screen indicating battery life.
- HCPs should take care to clear an occlusion alarm properly. The battery should not be cycled (turned on/off) to clear the occlusion alarm. If the occlusion alarm cannot be cleared, a new pump should be used. Patients should be educated that silencing the alarm does not clear the occlusion.
- Due to the potential ambulatory use of the pump, patients may carry the drug product dispensing pouch in a carrying pack. Patients should be educated that impeding the tubing set or placing pressure on the device (leaning against it, sitting on it) may cause the device to malfunction.
- HCPs are encouraged to educate patients on potential drug leakage and establish appropriate containment protocols for users to follow.
HCPs should ensure users are educated to recognize audio and visual alarms and inspect their device for damage. Any difficulties or abnormalities noted with the pump or accessories should result in immediate discontinued use of the pump and notification to the HCP. Customers of InfuTronix who have Nimbus Infusion Pumps and associated infusion sets in their possession should contact InfuTronix customer service, where they will be instructed on the Return Material Authorization (RMA) process to be followed for returning both the Nimbus Infusion Pumps and associated infusion sets.
Customers who purchase the Nimbus Infusion Pump and/or associated infusion sets from a distributor should contact their distributor directly and receive instructions on the RMA process to be followed. As the device will not be available or supported after June 20, 2024, InfuTronix encourages the healthcare provider to seek alternative methods of drug product infusion appropriate for their patient’s needs, based on their medical expertise, at the earliest possible opportunity. InfuTronix is removing the Nimbus Infusion Pump Systems from the market.
The products will no longer be supported by InfuTronix for either Nimbus Infusion Pumps or related infusion sets beyond June 20, 2024. To return Nimbus products customers should follow the instructions provided in the Medical Device Removal letter that was sent by InfuTronix, contact InfuTronix customer service or their local distributor.
Company name: InfuTronix, LLC
Brand name: Nimbus
Product recalled: Nimbus Pump System
Reason of the recall: Recall due to a high number (3698) of customer complaints related to the Nimbus Infusion Pump systems
FDA Recall date: March 20, 2024
Source: www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/voluntary-removal-announcement-infutronix-nimbus-ambulatory-infusion-pump-system
303
Pet Food, Wyoming, MI, USA
2 weeks ago •reported by user-rqkv1284
Acana cat food made my cats sick almost killing one. MANY brands of pet food are making pets sick and/or killing them. drjudymorgane January 18, 2024 Pet parent consumer reports of bloody diarrhea, vomiting, lethargy, food refusal, feeding: - 4Health - Orijen - Acana - Organix -
…
Blue Buffalo - Pure Balance - Hill's - Purina - Instinct - Royal Canin - Kirkland - Stella & Chewy's - Merrick - Taste of the Wild *This list will be updated as new reports come in 2,012 likes *At this time there are no official recalls for these brands yet. Samples have been sent to an independent laboratory for testing. Toxicology reports pending investigation.
296
R
user-rzfcf411
Hi, you can sign up for email alerts on recalled or food issues at the FDA website. FDA gov
- 1 week ago
- Reply
Did not purchase Verti Biorebose, Portland, OR, USA
2 weeks ago •reported by user-prpg3483
White bubble type envelope from Florida Not sure what ingredients are or what it’s for
Charged credit card twice for pills and an app that I did not order or receive!!!!
Charged credit card twice for pills and an app that I did not order or receive!!!!
712
Faults advertising, Columbus, OH, USA
1 week ago •reported by user-dbyfd382
Ordered 2 plug in rechargeable lighters. No gas product required per add. USB plug in 2hour charge good to go. No USB PLUG IN. False advertisement. Note fuel port. MADE IN CHINA. ADD Says U.S. company. Please refund me. Thank you. WEB SITE. Shopbrightfire. com phone# 1-888-863-4529
607
Report by
Thank you for your report!
IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)
Visit our learn pages for more helpful information or, email us: support@safelyhq.com
Goodbye! and best wishes in your recovery
Last 30 days